National Institute of Mental Health; Notice of Closed Meeting, 25289-25290 [2019-11338]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 105 / Friday, May 31, 2019 / Notices
Users.’’ International Journal of Drug
Policy, vol. 33, pp. 23:37–44, 2012.
8. Bicket, M., Long, J., Pronovost, P., et al.,
‘‘Prescription Opioid Analgesics
Commonly Used After Surgery: A
Systematic Review.’’ JAMA Surgery, vol.
152, pp. 1066–1071, 2017 (available at
doi:10.1001/jamasurg.2017.0831,
published online August 2, 2017).
9. Howard, R., Fry, B., Gunaseelan, V., et al.,
‘‘Association of Opioid Prescribing with
Opioid Consumption After Surgery in
Michigan.’’ JAMA Surgery, vol. 154, p.
e184234, 2019 (available at doi:10.001/
jamasurg.2018.4234, published online
November 7, 2018).
10. Thiels, C., Ubl, D., Yost, K., et al.,
‘‘Results of a Prospective, Multicenter
Initiative Aimed at Developing OpioidPrescribing Guidelines After Surgery.’’
Annals of Surgery, vol. 268, pp. 457–468,
2018 (available at doi:10.1097/
SLA.0000000000002919).
11. Mundkur, M., Meyer, T., Menzin, T., et
al., ‘‘Estimating the Optimal Duration of
Initial Opioid Analgesic Prescriptions in
Post-Surgical Populations Using FDA’s
Sentinel Distributed Database.’’
Pharmacoepidemiology and Drug Safety,
S2: Abstracts of the 34th International
Conference on Pharmacoepidemiology &
Therapeutic Risk Management, Abstract
#392, vol. 27, p. 181 (available at
doi:10.1002/pds.4629).
12. Steiner, C.A., Karaca, Z., Moore, B.J., et
al., ‘‘Surgeries in Hospital-Based
Ambulatory Surgery and Hospital
Inpatient Settings, 2014.’’ HCUP
Statistical Brief #223, 2017 (available at
www.hcup-us.ahrq.gov/reports/
statbriefs/sb223-Ambulatory-InpatientSurgeries-2014.pdf).
13. Mundkur, M., unpublished data.
* 14. Mundkur, M., Franklin, J., Abdia, Y., et
al., ‘‘Days’ Supply of Initial Opioid
Analgesic Prescriptions and Additional
Fills for Acute Pain Conditions Treated
in the Primary Care Setting—United
States, 2014.’’ Morbidity and Mortality
Weekly Report, vol. 68, pp. 140–143,
2019.
* 15. Dowel, D., Haegerich, T., and Chou, R.,
‘‘CDC Guideline for Prescribing Opioids
for Chronic Pain—United States, 2016.’’
Morbidity and Mortality Recommended
Weekly Report, vol. 65(1), pp. 1–49,
2016.
16. Opiate Prescribing Engagement Network,
‘‘Emergency Department Prescribing
Recommendations’’ (available at https://
michigan-open.org/emergencydepartment-prescribingrecommendations/), accessed January 5,
2019.
17. Ohio Opiate Action Team, ‘‘Ohio
Guidelines for Emergency and Acute
Care Facility Opioid and Other
Controlled Substances (OOCS)
Prescribing’’ (available at https://
mha.ohio.gov/Portals/0/assets/
Initiatives/GCOAT/Guidelines-ED-AcuteCare.pdf), accessed January 5, 2019.
18. New York City Emergency Department,
‘‘Discharge Opioid Prescribing
Guidelines’’ (available at https://
www1.nyc.gov/assets/doh/downloads/
VerDate Sep<11>2014
16:42 May 30, 2019
Jkt 247001
pdf/basas/opioid-prescribingguidelines.pdf), accessed January 5,
2019.
19. Thiels, C., Ubl, D., Yost, K., et al.,
‘‘Results of a Prospective, Multicenter
Initiative Aimed at Developing OpioidPrescribing Guidelines After Surgery.’’
Annals of Surgery, vol. 268, pp. 457–468,
2018.
20. The Regents of the University of
Michigan, ‘‘Opioid Prescribing
Recommendations for Surgery’’
(available at https://
opioidprescribing.info/), last updated
April 11, 2019, accessed April 17, 2019.
21. Overton, H., Hanna, M., Bruhn, W., et al.,
‘‘Opioid-Prescribing Guidelines for
Common Surgical Procedures: An Expert
Panel Consensus.’’ Journal of the
American College of Surgeons, vol. 227,
pp. 411–418, 2018.
Dated: May 24, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–11283 Filed 5–30–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Lung Cellular,
Molecular, and Immunobiology Study
Section, June 4, 2019, 08:00 a.m. to June
5, 2019, 03:00 p.m., Hilton Baltimore
Inner Harbor, 401 W Pratt Street,
Baltimore, MD 21201, which was
published in the Federal Register on
April 16, 2019, 84 FR PG 15624.
The meeting location is being changed
to Hilton Baltimore Inner Harbor, 401 W
Pratt Street, Baltimore, MD 21201.
Meeting dates remain the same. The
meeting is closed to the public.
Dated: May 24, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11328 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
25289
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NIMH Pilot Effectiveness Trials for
Treatment, Preventive, and Services
Interventions (R34).
Date: June 18, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NCDDG & First in Human and Early Stage
Clinical Trials for Psychiatric Disorders.
Date: June 18, 2019.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Building in vivo Preclinical Assays of Circuit
Engagement for Application in Therapeutic
Development (R01).
Date: June 25, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
E:\FR\FM\31MYN1.SGM
31MYN1
25290
Federal Register / Vol. 84, No. 105 / Friday, May 31, 2019 / Notices
Dated: May 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11338 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetics
of Health and Disease Study Section.
Date: June 24–25, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Christopher Payne, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, christopher.payne@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: June 27, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 E Wacker Dr., Chicago, IL
60601.
Contact Person: Clara M. Cheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
1041, chengc@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 3:00 p.m.
VerDate Sep<11>2014
16:42 May 30, 2019
Jkt 247001
Agenda: To review and evaluate grant
applications.
Place: Marines Memorial Club and Hotel,
609 Sutter Street, San Francisco, CA 94102.
Contact Person: Joanne T. Fujii, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Medical Imaging.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Leonid V. Tsap, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7854, Bethesda, MD 20892, (301) 435–
2507, tsapl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Microbial
(non-HIV) Diagnostics and Food Safety,
Sterilization/Disinfection, and
Bioremediation.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 E Wacker Street, Chicago, IL
60601.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Psycho/Neuropathology Lifespan
Development, STEM Education.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Seattle, 1400 Sixth
Avenue, Seattle, WA 98101.
Contact Person: Elia E. Femia, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–827–7189,
femiaee@csr.nih.gov.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Georgetown, 2350 M
Street NW, Washington, DC 20037.
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory and Motor
Neuroscience, Cognition and Perception.
Date: June 27–28, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington DC, 923
16th Street NW, Washington, DC 20006.
Contact Person: Sharon S. Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7846, Bethesda, MD 20892, 301–237–
1487, lowss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Immunology.
Date: June 27–28, 2019.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Liying Guo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016F,
Bethesda, MD 20892, 301–435–0908, lguo@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; U.S. China
Program for Biomedical Collaborative
Research.
Date: June 27, 2019.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ola Mae Zack Howard,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7806, Bethesda, MD 20892, 301–451–
4467, howardz@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
19–016: Transformative Research (R01) to
Understand Down Syndrome.
Date: June 27, 2019.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 84, Number 105 (Friday, May 31, 2019)]
[Notices]
[Pages 25289-25290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11338]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; NIMH Pilot Effectiveness Trials for Treatment,
Preventive, and Services Interventions (R34).
Date: June 18, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892, 301-443-9699,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; NCDDG & First in Human and Early Stage Clinical
Trials for Psychiatric Disorders.
Date: June 18, 2019.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Vinod Charles, Ph.D., Scientific Review Officer,
Division of Extramural Activities, National Institute of Mental
Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6151,
MSC 9606, Bethesda, MD 20892, 301-443-1606, [email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Building in vivo Preclinical Assays of Circuit
Engagement for Application in Therapeutic Development (R01).
Date: June 25, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Rebecca Steiner Garcia, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6149, MSC 9608, Bethesda, MD 20892, 301-443-4525,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
[[Page 25290]]
Dated: May 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-11338 Filed 5-30-19; 8:45 am]
BILLING CODE 4140-01-P
